An AI-native pharmaceutical company launched with approximately $1 billion, integrating Protein Design and the Virtual Cell 'X-Cell'The reason for featuring Xaira Therapeutics in this 20-company ...

In vegetated environments, such as forests, exploratory robots play a vital role in navigating complex, cluttered ...

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

This score calculates overall vulnerability severity from 0 to 10 and is based on the Common Vulnerability Scoring System (CVSS). Attack Vector: This metric reflects the context by which vulnerability ...

Lilian Weng spent nearly seven years building OpenAI's safety infrastructure — the fine-tuning API, the moderation endpoints, and eventually a unified team of more than 80 scientists — and now, as of ...

Clinical trials are notoriously difficult to predict, and they have grown more so as protocols pile on endpoints, procedures and eligibility rules. As that complexity climbs, so do the odds of studies ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

Huawei unveiled the full-stack data infrastructure solution of AI DCs to accelerate AI DC construction and large-scale AI adoption for enterprises. (Google Gemini) Paris, France, May 25, 2026 - At the ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...